Form D · Other Health Care

Averify, LLC

Dallas, TX · CIK 0001645725

Offering snapshot reported Apr 28, 2016 · SEC filing

Reported sold
$175K
Offering amount: $700K
Investors reported
3
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Feb 9, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 28, 2016Initial$175,000No comparison3SEC filing
Jun 29, 2015Initial$365,000No comparison3SEC filing
Jun 29, 2015Initial$65,000No comparison1SEC filing
Jun 29, 2015Initial$300,000No comparison1SEC filing
Jun 29, 2015Initial$450,000No comparison1SEC filing

Offering details

Securities
Debt, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-262236

Source: Form D, filed Apr 28, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jim Duda Director
Catherine A. Fogliano Director
William M. Giles Director, Executive
Frank M. Roby Director, Executive
Craig R. Shackelton Director, Executive
Craig R. Shackleton Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
3102 Oak Lawn Ave. Suite 615
Dallas, TX, 75219